NOS2 and central nervous system cancer: Based on its promising in vitro activity, CM544 was evaluated on rat astrocytes and C6 rat glioma cells, confirming the elevated selectivity towards iNOS, being the compound ineffective on normal astrocytes as they do not express the inducible isoform of the enzyme [31].